# Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, UNCOVER-2, and UNCOVER-3

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/ixekizumab-treatment-shows-a-neutral-impact-on-cardiovascular-parameters-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Alexander Egeberg,Jashin J. Wu,Neil J. Korman,James Solomon,Orin M. Goldblum,Fangyi Zhao,Lotus Mallbris |
| Citations | 65 |
| DOI | 10.1016/j.jaad.2018.02.074 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://stars.library.ucf.edu/scopus2015/8515 |
| OpenAlex ID | https://openalex.org/W2791445230 |
| PMID | 29548945 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Orin M. Goldblum](https://scholariq.org/researchers/orin-m-goldblum/)

## Paper primary topic

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

## Paper topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.